Proteflazid drops bottle 50 ml

1 ml of drops contains 1 ml of liquid extract Proteflazid (flavonoid content of at least 0.32 mg/ml in terms of rutin, carboxylic acid content of at least 0.30 mg/ml in terms of malic acid) from the grass of Sodden Pike (Herba Deschampsia caespitosa L.) and the grass of Ground Warbler (Herba Calamagrostis epigeios L.) (1:1).

Extraction solvent: ethanol 96%.

Hypersensitivity to the components of the drug. Gastric or duodenal ulcer.

Allergic reactions: Hypersensitivity reactions may occur in susceptible individuals. Rarely, allergic reactions may occur, including erythematous rashes and itching.

On the part of the digestive system: isolated cases of gastrointestinal disorders are observed – pain in the epigastric region, nausea, vomiting, diarrhea. In patients with chronic gastroduodenitis, exacerbation of gastroduodenitis and the occurrence of gastroesophageal reflux (reflux esophagitis) are possible.

General disorders: in rare cases, headache, general weakness, transient increase in body temperature up to 38 °C on the 3rd-10th day of drug therapy are possible.

Laboratory indicators: during the treatment of viral hepatitis, 10-15% of patients with severe cytolytic syndrome experience an increase in aminotransferase activity (less often, bilirubin levels).

Local reactions: with local application, a burning sensation, itching, and dryness may occur.

In case of any adverse reactions, you should consult a doctor.

The bottle must be shaken before use.

The drug is dosed using a dropper. The required amount of the drug should be dripped into water (volume – 1-2 tablespoons), taken 10-15 minutes before meals.

Proteflazid® drops dosage regimen, depending on age

• from birth to 1 year – 1 drop per day;
• 1 – 2 years – 1 drop 2 times a day;
• 2 – 4 years – 2 drops 2 times a day;
• 4 – 6 years – 4 drops 2 times a day;
• 6 – 9 years – 9 drops 2 times a day;
• 9 – 12 years – 10 drops 2 times a day;
• children over 12 years old and adults – 12-15 drops 2 times a day.

The duration of use of Proteflazid depends on the indications and course of the disease.

Use during pregnancy or breastfeeding

In preclinical studies, no embryotoxic, teratogenic, fetotoxic, mutagenic and carcinogenic effects were detected. Special studies on such effects of the drug on the human fetus have not been conducted, but clinical experience with the use of the drug in the I-III trimesters of pregnancy and during breastfeeding has not revealed any negative effects. The decision on the advisability of using the drug during pregnancy or breastfeeding is made by a doctor.

Children

The drug Proteflazid is used for children from birth.

The ability to influence the reaction speed when driving or working with other mechanisms

When used in recommended doses, no negative effects on the ability to perform work requiring special attention and quick reactions were detected.

Cases of overdose are unknown, but side effects may develop, especially from the gastrointestinal tract. Treatment is symptomatic.

In case of an overdose of Proteflazid, you should immediately consult a doctor.

During clinical use, the possibility and feasibility of combining Proteflazid with antibiotics and antifungal drugs for the treatment of viral-bacterial and viral-fungal diseases have been established. No negative manifestations due to interaction with other drugs have been identified.

Store in the original packaging at a temperature not exceeding 25 °C.

Do not freeze!

It is permissible to form a gel-like structure that collapses when shaken. Keep out of the reach of children.